Document:

Exhibit

Exhibit 10.2

CERTAIN IDENTIFIED INFORMATION HAS BEEN EXCLUDED FROM THIS EXHIBIT BECAUSE IT IS BOTH (I) NOT MATERIAL AND (II) WOULD BE COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED.  SUCH PORTIONS ARE MARKED AS INDICATED WITH BRACKETS (“[***]”) BELOW.

Amendment to the Joint Venture Contract of Exoskeleton Intelligent Robotics Co. Limited
爱科索智能机器人有限公司的合资经营合同的修订

WHEREAS, Zhejiang Youchuang Venture Capital Investment Co., Ltd., a company organized under the laws of the PRC (“Youchuang”), Shaoxing City Keqiao District Paradise Silicon Intelligent Robot Industrial Investment Partnership (Limited Partnership) (“Industrial Investment Fund”), a limited liability partnership organized under the laws of the PRC ("Industrial Investment Fund"), Ekso Bionics, Inc., a company organized under the laws of the State of Delaware, USA (“Ekso Bionics”) entered into a joint venture contract for the establishment, operation, and governance of Exoskeleton Intelligent Robotics Co. Limited (the “Company” or the “Joint Venture”) on 30 January 2019 (the “Contract”). (Youchuang, Industrial Investment Fund and Ekso Bionics are collectively referred to as the “Parties” and individually referred to as a “Party” herein).
鉴于, 浙江优创创业投资有限公司(一家根据中国法律成立的公司, 下文简称“优创”)、绍兴市柯桥区天堂硅谷智能机器人产业投资合伙企业(有限合伙)(一家根据中国法律成立的有限合伙企业,下文简称“产业投资基金”), 以及爱科索仿生机械有限公司(一家根据美国特拉华州法律成立的公司,下文简称“爱科索”)于2019年1月30日共同签署了关于成立、运营和管理爱科索智能机器人有限公司(下文简称“公司”或“合资公司”) 的合资合同 (下文简称“《合资合同》”) (优创、产业投资基金和爱科索统称为“各方”་单独称为“一方”。)

WHEREAS, the Parties have agreed to enter into this agreement on April 30, 2019 to revise certain clauses in the Contract (the “Amendment”).
鉴于,各方一致同意于2019年4月30日签署本修订以修改《合资合同》中的特定条款 (下文简称“修订”)。

		
	1.
	The Parties acknowledge and agree that Section 4.2 of the Contract would be revised as follows:

各方认可并同意,《合资合同》的第4.2条修改如下:

4.2     经营范围。生产、销售、研发可穿戴式仿生外骨骼机器人产品及其零部件་以及相关技术的推广和维护。涉及许可证的凭证经营。(具体经营范围应经主管政府当局批准)
Scope of Business. manufacture, sales, develop and research of wearable and bionic exoskeleton products and related components and subassemblies, technology promotion and services of such relevant technology. Licenses for operation should be obtained if required. (the specific scope shall be subject to the approval of competent Governmental Authorities).

		
	2.
	The Parties acknowledge and agree that Section 4.5 (a)(xii) would be revised as follows:

各方认可并同意,《合资合同》的第4.5 (a)(xii)条修改如下:

(xii)  合资公司能够生产制造合格的EksoGT、EksoVest和EksoZeroG Arm产品后་自向爱科索、其关联方和合同区域内的任何第三方卖家发运第一批现有产品༈即成品་以及目前的Ekso GT配件([***]) (“发货日期”) 后 30个工作日内་合资公司或优创或优创指定第三方将向 Ekso Bionics Holdings, Inc. 支付伍佰万美元 (USD 5,000,000) 作为股权投资。股权投资价格为发货日期之前20个交易日的成交量加权平均价་但此时的股权价格应不超过首次投资的股权价格的[***]%,同时也不低于首次投资的股权价格的[***]% (首次投资是指签署《合资合同》后的首个500万美元的股权投资)。
After the Joint Venture is able to manufacture qualified EksoGT, EksoVest and EksoZeroG Arm products, the Joint Venture or Youchuang or the third party designated by Youchuang will invest USD Five Million (5,000,000) in Ekso Bionics as the equity investment within thirty business days after issuing the first batch of Current Products ([***]) to Ekso Bionics, its Affiliates or any third party buyer located in the Territory (“Shipment Date”). The equity investment price will be the volume weighted average price of 20 trading days before the Shipment Date, but with a collar so that the equity price will be no greater than [***]% higher than the first investment and no lower than [***]% of the first investment price. (First investment is the first 5 $mm investment made after signing the joint venture contract).

		
	3.
	The Parties acknowledge and agree that Section 5.2 (d) would be revised as below:

各方认可并同意,《合资合同》的第5.2 (d)条修改如下:

		
	(d)
	合同各方应按以下要求出资:

The Parties shall make their capital contribution to the Company as follows:
		
	(i)
	优创应自合资公司成立日期起[***], 支付[***]%出资额; 余下的认缴出资应[***]缴付;

Youchuang shall make [***]% of its capital contribution within [***]from the Establishment Date of the Company and the remaining subscribed capital contribution shall be paid in [***]. 

		
	(ii)
	产业投资基金应自合资公司成立日期起[***]内, 支付[***]%出资额; 余下的认缴出资应[***]缴付; 

Industrial Investment Fund shall make [***]% of its capital contribution within [***] from the Establishment Date of the Company and the remaining subscribed capital contribution shall be paid in [***]. 
		
	 
	 

		
	(iii)
	爱科索应自合资公司成立日期起[***]内向合资公司完成出资技术文本转让移交་[***]内在中国国家知识产权局完成专利权的转让登记;

Ekso Bionics shall complete the transfer of all relevant Technical Documentation of contribution within [***] from the Establishment Date. The completion of the Patent Rights transfer registration with CNIPA within [***].

		
	 (iv)
	在优创和产业投资基金分别按照第5.2(d)(i)条和第5.2(d)(ii)条的约定实缴其首期现金出资后, 中方股东的剩余认缴出资应当按照以下方式支:

After the initial cash capital contribution described in Sections 5.2 (d) (i) and 5.2(d) (ii) have been paid by Youchuang and the Industrial Investment Fund, the remaining subscribed capital contribution shall be paid in the following manner:
        
		
	•
	当公司现金余额低于[***]优创和产业投资基金应在合资公司缴付通知发出的约定缴付期限及缴付金额按各自比例完成当期实缴出资 (每次共计不少于3120万元, 占优创和产业基金总出资额的5%), 以满足当时的运营计划的要求་除非总经理提供说明公司有足够的资金来满足当时的运营计划的要求。

When the Company’s cash balance falls below [***], Youchuang and the Industrial Investment Fund shall make their capital contribution in accordance with the term and amount prescribed in the paid-in notice issued by the Company in their respective proportionate amount to meet the requirements of the then current Operating Plan (the aggregate amount for each installment of such capital contribution should be no less than RMB 31,200,000 representing five percent (5%) of Youchuang’s and the Industrial Investment Fund’s total capital contribution), unless the General Manager provides an explanation that the Company has sufficient funds to meet the requirements of the then current Operating Plan.

		
	•
	当优创和产业基金的实缴出资额达到人民币1.872亿元后(即占优创和产业基金总出资额的30%), 优创和产业基金可根据合资公司的发展情况་按其各自的比例不时缴纳余下的认缴出资་并自合资公司成立之日起十年之内完成出资 ([***])。

When Youchuang and the Industrial Investment Fund’s cumulative  aggregate paid-in capital contributions exceed RMB 187,200,000 (representing 30% of Youchuang’s and the Industrial Investment Fund’s total capital contribution) then based on the development of the Company, the remaining subscribed capital contribution shall be made in their respective proportion amount from time to time within the ten (10) year term of the Establishment Date ([***]).
		
	4.
	The Parties acknowledge and agree that Section 8.1(b) would be revised as below:

各方认可并同意,《合资合同》的第8.1(b)条修改如下:

		
	(b)
	总经理应由爱科索和优创共同任命 (决定权由优创掌握), 并经董事会批准。[***]将担任公司的法人代表。首席财务官应由优创任命, 并经董事会批准。

The General Manager shall be mutually nominated by Ekso Bionics and Youchuang where Youchuang has the right to make a final decision, and approved by the Board.  [***] will be the legal representative of the Company.  The Chief Financial Officer shall be nominated by Youchuang, and shall be approved by the Board.
		
	5.
	This Amendment is a revision and supplement to the Contract, which forms an indispensable part of the Contract. Where there is any inconsistency between this Amendment and the Contract, the terms of this Amendment shall prevail; and where 

any terms are not provided herein, the terms prescribed in the Contract are still effective among the Parties and should be performed.
本修订是对《合资合同》的修订和补充་构成《合资合同》不可缺少的一部分。《合资合同》中与本修订如有不一致之处་以本修订的约定为准༛本修订未作约定的条款་《合资合同》的约定仍有效并应遵照其执行。

		
	6.
	Except as otherwise defined in this Amendment, the terms used in this Amendment shall have the same meaning as specified in the Contract.

除本修订另有定义之外, 本修订所用语词应具有《合资合同》项下所规定的相同含义。

		
	7.
	This Amendment should be executed in six (6) original copies and each Party hold two (2) copies, each of which is equally legal binding.

本修订一式陆 (6) 份, 各方各执贰(2) 份, 每份均具有同等的法律效力。

		
	8.
	This Amendment shall become effective upon the execution by the duly authorized representative of the Parties.

本修订自各方正式授权代表签署之日生效。

[The remainder of this page is intentionally left blank; signature page follows]
[本页剩余部分留白་签署页后附]

Signature Page of Amendment to the Joint Venture Contract of Exoskeleton Intelligent Robotics Co. Limited
爱科索智能机器人有限公司合资合同的修订签署页

This Amendment is executed by the duly authorized representative of the Parties, on the date and year fist indicated above.

	
	
	

浙江优创创业投资有限公司(公司印章)
Zhejiang Youchuang Venture Capital Investment Co., Ltd. (Company Seal)

	

签署人
                 
By  /s/ 吴建龙         

姓名:
Name:   
职务:
 
Title:   

Signature Page of Amendment to the Joint Venture Contract of Exoskeleton Intelligent Robotics Co. Limited
爱科索智能机器人有限公司合资合同的修订签署页

This Amendment is executed by the duly authorized representative of the Parties, on the date and year fist indicated above.

	
	
	

绍兴市柯桥区天堂硅谷智能机器人产业投资合伙企业 (有限合伙) (公章)
Shaoxing City Keqiao District Paradise Silicon Intelligent Robot Industrial Investment Partnership (Iimited Partnership) (Company Seal)

	

签署人
                 
By /s/ 包雪青        

姓名:
Name:   
职务:
 
Title:   

Signature Page of Amendment to the Joint Venture Contract of Exoskeleton Intelligent Robotics Co. Limited
爱科索智能机器人有限公司合资合同的修订签署页

This Amendment is executed by the duly authorized representative of the Parties, on the date and year fist indicated above.

	
	
	

爱科索仿生机械有限公司
Ekso Bionics, Inc.

	

签署人
                 
By   /s/ Jack Peurach               

姓名:
Name:   Jack Peurach
职务:
 
Title:   CEO   

	签署和背书人:
SIGNED AND ENDORSED BY:

Ekso Bionics Holdings, Inc.

签署人                        
By    /s/ John F. Glenn        

姓名:    
Name:    John F. Glenn
职务:    
Title:    CFOExhibit

Exhibit 10.12

Social Award Agreement
This Social Award Agreement (this “Agreement”) is made as of May 7, 2019 by and between SciPlay Corporation, a Nevada corporation (“SciPlay”), and M. Mendel Pinson (“Pinson”).
WHEREAS, Scientific Games Corporation, a Nevada corporation (“SciGames”), has been pursuing a potential initial public offering of a minority stake in its Social Gaming business, which would involve the issuance and sale of shares of Class A common stock of SciPlay (such shares, the “SciPlay Shares” and, such offering, the “Social IPO”);
WHEREAS, Pinson has provided substantial services on behalf of SciPlay and its subsidiaries and affiliates, including the provision of strategic advice regarding corporate development and strategy, including in connection with pursuing the Social IPO; 
WHEREAS, in anticipation of, and following, the Social IPO, Pinson is expected to continue to provide substantial services on behalf of SciPlay and its subsidiaries and affiliates, leading SciPlay’s corporate development and strategy efforts, and providing SciPlay with strategic advice to shape and direct its corporate development and strategy (the “Services”); and
WHEREAS, in connection with the Social IPO, in recognition for the substantial services Pinson has provided and in return for Pinson providing the Services, SciPlay desires to provide Pinson with a long-term incentive award on the terms and conditions set forth below.
NOW THEREFORE, in consideration of the premises and the mutual benefits to be derived herefrom and other good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties agree as follows:
		
	1.
	Effectiveness. This Agreement shall become effective upon the consummation of the Social IPO (such date, the “Effective Date”). The parties hereto acknowledge that this Agreement is expressly contingent upon the consummation of the Social IPO and that in the event SciGames determines not to consummate the Social IPO, this Agreement shall be null and void ab initio.

		
	2.
	Definitions.  As used in this Agreement, the following terms have the following meanings:

		
	a.
	“2017 Adjusted EBITDA” means $100 million.

		
	b.
	“2017 Revenue” means $360 million.

		
	c.
	“2020 Adjusted EBITDA” means Adjusted EBITDA for SciPlay and its subsidiaries for the 2020 fiscal year excluding: (i) non-recurring or one-time financial results that the Committee determines must be excluded to ensure 2017 Adjusted EBITDA and 2020 Adjusted EBITDA are calculated on the same basis; (ii) the impact (positive or negative) of any acquisitions, joint ventures or other similar transactions completed on or after January 1, 2018 (collectively, “Transactions”), as determined by the Committee; and (iii) expenses that the Committee determines would not have been incurred by the Pre-IPO Business, such as expenses associated with being a public company. For the avoidance of doubt, 2020 Adjusted EBITDA shall be calculated on a basis consistent with 2017 Adjusted EBITDA both with respect to accounting principles and types of exclusions in a manner that is not to the benefit or the detriment of Pinson; provided that the Committee shall retain discretion to provide for different treatment with respect to different Transactions, based on considerations such as the applicable Transaction’s structure or financing arrangements.

		
	d.
	“2020 Revenue” means the Revenue of SciPlay and its subsidiaries for the 2020 fiscal year excluding: (i) non-recurring or one-time financial results that the Committee determines must be excluded to ensure 2017 Revenue and 2020 Revenue are calculated on the same basis; and (ii) the impact (positive or negative) of any Transactions, as determined by the Committee. For the avoidance of doubt, 2020 Revenue shall be calculated on a basis consistent with 2017 Revenue both with respect to accounting principles and types of exclusions in a manner that is not to the benefit or the detriment of Pinson; provided that the Committee shall retain discretion to provide for different treatment with respect to different Transactions, based on considerations such as the applicable Transaction’s structure or financing arrangements.

		
	e.
	“Adjusted EBITDA” means earnings before interest, tax, depreciation and amortization expense, adjusted to exclude:  (i) contingent acquisition consideration; (ii) restructuring and other, which includes charges or expenses attributable to: (1) employee severance; (2) management changes; (3) restructuring and integration; (4) M&A and other, which includes: (A) M&A transaction costs; (B) purchase accounting adjustments; (C) unusual items (including certain legal settlements); and (D) other non-cash items; and (5) cost-savings initiatives; (iii) stock-based compensation expense; (iv) loss (gain) on debt financing transactions; and (v) other non-operating expenses (income) including foreign currency (gains) and losses.

		
	f.
	“Committee” means the Compensation Committee of the Board of Directors of SciPlay; provided that, for purposes of administering the Social Award (as defined below), Pinson shall not be considered a member of the Committee and shall recuse himself from all applicable meetings.

		
	g.
	“Cause” means: (i) gross neglect by Pinson in the performance of the Services; (ii) Pinson’s indictment for or conviction of a felony, or any non-felony crime or offense involving the property of SciPlay or any of its subsidiaries or affiliates or evidencing moral turpitude; (iii) willful misconduct by Pinson in connection with the performance of the Services; (iv) material violation by Pinson of a material provision of SciPlay’s Code of Business Conduct, to the extent applicable to Pinson; or (v) any other willful or grossly negligent conduct of Pinson that would make the continued provision of the Services materially prejudicial to the best interests of SciPlay.

		
	h.
	“Good Reason” means that, without Pinson’s prior written consent, the following shall have occurred: (i) SciPlay materially reduces the scope of the Services or materially interferes with Pinson’s ability to perform the Services, except as a result of Pinson’s death, disability or termination for Cause; or (ii) any material failure by SciPlay to perform any material obligation under, or material breach by SciPlay of any material provision of, this Agreement; provided, however, that a termination by Pinson for Good Reason shall not be considered effective unless Pinson shall have provided SciPlay with written notice of the specific reasons for such termination within 30 days after he has knowledge of the event or circumstance constituting Good Reason and SciPlay shall have failed to cure the event or condition allegedly constituting Good Reason within 30 days after such notice has been given to SciPlay and Pinson actually terminates the Services within one year following the initial occurrence of the event giving rise to Good Reason.

		
	i.
	“Plan” means the SciPlay Corporation Long-Term Incentive Plan or, if by a different name, the long-term equity incentive plan of SciPlay in effect upon the consummation of the Social IPO.

		
	j.
	“Pre-IPO Business” means SciGames’ Social Gaming business, which for the 2017 fiscal year was comprised of SG Nevada Holding Company II, LLC (now known as SG Social Holding Company II, LLC) and all of its subsidiaries; provided that the Committee shall determine what constitutes the Pre-IPO Business.

		
	k.
	“Qualifying Termination” means a termination of the Services by SciPlay and its subsidiaries without Cause or by Pinson for Good Reason.

		
	l.
	“Revenue” means revenue, as determined in accordance with U.S. Generally Accepted Accounting Principles.

		
	3.
	Social Award Grant. The “Social Award” shall consist of performance-conditioned restricted stock units (“PRSUs”) with respect to SciPlay Shares.  The Social Award shall be granted effective as of the later of the consummation of the Social IPO and the first date on which the Plan has been approved by the Board of Directors of SciPlay and SciPlay’s stockholders.  The target number of PRSUs subject to the Social Award shall be equal to the number of SciPlay Shares determined by dividing $5 million by the initial offering price of a SciPlay Share in the Social IPO, as determined by the Pricing Committee (or other applicable committee) of the Board of Directors of SciPlay.     

		
	4.
	Vesting.  Provided (x) Pinson provides the Services through December 31, 2020 or (y) if Pinson earlier experiences a Qualifying Termination, one-third of the target number of PRSUs subject to the Social Award shall vest and become payable based on 2020 Revenue (the “Revenue PRSUs”) and two-thirds of the target number of PRSUs subject to the Social Award shall vest and become payable based on Adjusted EBITDA (the “AEBITDA PRSUs”), in each case, as set forth below. 

		
	a.
	The Revenue PRSUs shall be forfeited in their entirety if 2020 Revenue does not exceed 2017 Revenue, and shall vest at target if 2020 Revenue equals or exceeds $720 million.  If 2020 Revenue is between 2017 Revenue and $720 million, the number of Revenue PRSUs that vest shall be determined based on linear interpolation from 0% of the target number of Revenue PRSUs if 2020 Revenue equals 2017 Revenue to 100% of the target number of Revenue PRSUs if 2020 Revenue equals or exceeds $720 million.

		
	b.
	The AEBITDA PRSUs shall be forfeited in their entirety if 2020 Adjusted EBITDA does not exceed 2017 Adjusted EBITDA, and shall vest at target if 2020 Adjusted EBITDA equals or exceeds $250 million.  If 2020 Adjusted EBITDA is between 2017 Adjusted EBITDA and $250 million, the number of AEBITDA PRSUs that vest shall be determined based on linear interpolation from 0% of the target number of AEBITDA PRSUs if 2020 Adjusted EBITDA equals 2017 Adjusted EBITDA to 100% of the target number of AEBITDA PRSUs if 2020 Adjusted EBITDA equals or exceeds $250 million.  

		
	c.
	Notwithstanding anything in the award agreement to the contrary, the Committee may adjust the number of PRSUs that vest if it determines that, because of changes in the value of SciPlay Shares from the initial offering price of the Social IPO, vesting as set forth above would result in Pinson receiving substantially more or less in value than contemplated by the parties.  For example, if the stock price at the time of vesting is three times the initial offering price, such that if the Social Award fully vests Pinson would receive SciPlay Shares worth $15 million, the Committee may reduce the number of PRSUs that vest. In no event, however, shall any such increase or reduction in the number of PRSUs that vest result in Pinson receiving more or less in value than if the price per share of SciPlay Shares at the time of vesting is unchanged from the initial offering price of the Social IPO.

		
	5.
	Payment. The SciPlay Shares underlying the PRSUs that vest in accordance with Section 4 shall be delivered to Pinson as soon as practicable following the date on which SciPlay’s 2020 fiscal year results are audited and approved by the Committee, but in no event later than March 15, 2021.

		
	6.
	The Plan; Change in Control.  

		
	a.
	The Social Award shall be granted pursuant to the Plan, subject to the terms and conditions of the Plan, except to the extent otherwise provided herein, and evidenced by the execution of an award agreement pursuant thereto, but in all respects consistent with the terms of this Agreement. For the avoidance of doubt, notwithstanding anything in the Plan to the contrary, no terms of this Agreement shall be altered or diminished in any manner without the written consent of Pinson.  

		
	b.
	In the event a “Change in Control” (as defined in the Plan) occurs prior to the determination of the Committee of the number of PRSUs that vest pursuant to Section 4 of this Agreement or a forfeiture of the PRSUs in accordance with this Agreement, then (i) if a Qualifying Termination occurred prior to such Change in Control, then 2020 Revenue and 2020 Adjusted EBITDA shall be deemed achieved at $720 million and $250 million, respectively, such that Pinson shall vest in the target number of PRSUs or (ii) in all other cases, the Social Award shall be treated in accordance with Section 9(a) of the Plan (i.e., vest based on a performance level determined by the Committee); provided that the Committee shall have full discretion to adjust the form of consideration that may be payable in respect of the Social Award in connection with a Change in Control into cash or equity of the successor to, or parent entity of, SciPlay following such Change in Control on a basis providing for equal value at the time of such adjustment.  In the event the PRSUs vest in accordance with this Section 6(b), the consideration underlying such PRSUs shall be delivered to Pinson within 15 business days following the occurrence of the Change in Control. 

		
	7.
	Taxes.  Pinson shall be responsible for payment of all U.S. Federal, state, local and foreign taxes (collectively, “Taxes”) owed in respect of the Social Award, and SciPlay will not make any tax withholdings or deductions in respect thereof.  Pinson shall indemnify and hold harmless SciPlay and its affiliates from any liability, claims and demands for payment of Taxes, penalties or interest, social security, disability benefits and any other withholdings, deductions and payments that may be imposed by any governmental authority or otherwise authorized from, based upon or required solely by reason of the Social Award. Pinson and SciPlay acknowledge and agree that Pinson shall be permitted to sell SciPlay Shares in order to generate cash proceeds sufficient to pay the Taxes owed in respect of the Social Award, provided that Pinson complies with SciPlay’s Securities Trading Policy and all applicable laws. 

		
	8.
	Forfeiture; “Clawback” Policies.  For the avoidance of doubt, Section 8(g) of the Plan shall apply to the Social Award.  

		
	9.
	Construction.  The provisions of the Social Award shall be interpreted and administered as determined by the Committee in a manner to prevent duplication of the aggregate opportunity provided hereunder.

		
	10.
	Determinations by Committee.  All determinations by the Committee (or by the Board of Directors of SciPlay or any committee thereof) under this Agreement shall be made in its good faith and reasonable discretion, with Pinson having the opportunity to provide input to a member of the Committee (or the Board of Directors of SciPlay or any committee thereof, as applicable).  

		
	11.
	Governing Law; Arbitration. This Agreement shall be governed by and construed in accordance with the laws of the State of New York applicable to agreements made and to be wholly performed within that State, without regard to its conflict of laws provisions.

		
	12.
	Counterparts.  This Agreement may be executed in counterparts, each of which shall for all purposes be deemed to be an original and all of which shall constitute the same instrument.  Delivery of an executed counterpart of a signature page of this Agreement by electronic transmission shall be effective as delivery of a manually executed counterpart of this Agreement.

		
	13.
	Survivability.  The provisions of this Agreement which by their terms call for performance subsequent to termination of the Services, or of this Agreement, shall so survive such termination, whether or not such provisions expressly state that they shall so survive.

		
	14.
	Notices.  All notices and other communications to be given or to otherwise be made to any party to this Agreement shall be deemed to be sufficient if contained in a written instrument delivered in person or duly sent by certified mail or by a recognized national courier service, postage or charges prepaid, (a) to SciPlay, at 6601 Bermuda Road, Las Vegas, NV 89119, Attn: General Counsel, (b) to Pinson, at the last address shown in the Company’s records or (c) to such other replacement address as may be designated in writing by the addressee to the addressor.    

[Signature Page Follows]

1

IN WITNESS WHEREOF, each of the parties hereto has duly executed this Agreement as of May 7, 2019.
SCIPLAY CORPORATION

By: /s/ Josh Wilson    
Name: Josh Wilson
Title:    CEO

/s/ M. Mendel Pinson                 
M. Mendel Pinson

    

[Signature Page to Social Award Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00298-of-00352.parquet"}]]